Results 11 to 20 of about 113,618,068 (200)
Comparison of the performance of three cancer antigen (CA) 15-3 immunoassays [PDF]
Journal of Health Sciences, 2016 Introduction: In the present study we investigated the performance, precision, and recovery of three different automated methods in determining cancer antigen (CA) 15-3 levels. Methods: Serum samples were obtained from 60 hospitalized female patients. As
Nafija Serdarevic +2 more
doaj +4 more sources
The International Journal of Biological Markers, 1990 CEA, TPA, CA 15-3 were assayed in 238 patients in follow-up for breast cancer after surgery. CA 15-3 showed the best sensitivity and specificity; the predictive value of a positive CA 15-3 test was three times higher than CEA and TPA.
F. Caponigro +7 more
doaj +5 more sources
CA 15-3, Ceruloplasmin and tissue polypeptide specific antigen as a tumour marker panel in breast cancer [PDF]
East African Medical Journal, 2009 Tumour markers along with other tests, may be useful in the assessment of the prognosis, monitoring response to treatment and early detection of metastases in breast cancer. The most commonly used breast cancer antigen is CA 15-3.To examine the value of CA 15-3, ceruloplasmin and tissue polypeptide specific antigen (TPS) panel in the monitoring of ...
Kirazli, S, Baltali, E, Ozyilkan, O
openaire +6 more sources
Biosensors, 2023 An electrochemiluminescence-electrochemistry (ECL-EC) dual-mode sensing platform based on a vertically-ordered mesoporous silica films (VMSF) modified electrode was designed here for the sensitive and selective determination of cancer antigen 15-3 (CA 15-
Jie Huang +3 more
doaj +2 more sources
AnalyticaA disposable voltammetric immunosensor was developed to measure breast cancer biomarker 15-3 (CA 15-3) in human saliva and serum samples. Screen-printed paper-based electrodes (f-SPE) previously fabricated by our research group using homemade conductive ...
Ana Elisa F. Oliveira +3 more
doaj +2 more sources
Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment [PDF]
BMC Cancer, 2006 Background At many centres tumour markers are used to detect disease recurrence and to monitor response to therapy in patients with advanced disease, although the real value of serial observation of marker levels remains disputed.
Locker Gottfried J +9 more
doaj +3 more sources
European Journal of Cancer and Clinical Oncology, 1991 A new tumour marker, mucin-like carcinoma-associated antigen (MCA), was evaluated in 176 breast cancer patients classified either as free of tumour (NED, n = 141) or as having metastases (PD, n = 35). During the 5 year follow-up, 842 measurements of MCA and 363 measurements of CA 15-3 were done.
MACKE, H +5 more
openaire +5 more sources
Discovery of a Sinusoidal Pattern in the Cancer Antigen 15-3 Time Series of a Patient with Metastatic Breast Cancer [PDF]
Applied Medical InformaticsCancer Antigen 15-3 (CA 15-3) is a glycoprotein commonly linked to breast cancer. Monitoring CA 15-3 levels is crucial for tracking disease progression and evaluating treatment response in patients with metastatic breast cancer. Although fluctuations in
Alexandros CLOUVAS
doaj +1 more source
The International Journal of Biological Markers, 1991 CA 15-3, TPA and CEA were assayed before surgery in 60 patients with breast cancer. A significant association was found between preoperative CA 15-3 levels and some of the most important prognostic factors in breast cancer, such as lymph node status and ...
R.V. Iaffaioli +8 more
doaj +3 more sources
Breast Cancer Research and Treatment, 2001 The efficacy of CEA and CA15-3 tumor markers in monitoring breast cancer was evaluated in 1365 patients with either benign (n = 534) or malignant (n = 831) breast diseases. Thirty-nine breast cancer patients were monitored before and after neoadjuvant chemotherapy.
D'Alessandro, R +17 more
openaire +4 more sources